Clinical Trial

Nebulized Lidocaine And Ketamine Before Fiberoptic Bronchoscopy

Completed Phase 4
View on ClinicalTrials.gov →
Summary
The current study is looked for the comparison between nebulized lidocaine and ketamine, nebulized lidocaine, and usual lidocaine spray in the oral and nasal cavities before flexible bronchoscopy. The investigators are looking for different outcomes including mainly cough suppression during the procedure, patient tolerance and discomfort, operator and patients' satisfaction, and safety of the use of these medications especially regarding nebulized ketamine.
Trial Details
NCT Number NCT07743333
Lead Sponsor Alexandria University
Conditions Fiberoptic Bronchoscopy (FOB), Lung Cancer (Diagnosis), Premedication
Enrollment 134 participants
Start Date 2024-09-01
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-08-03